ArticleMicrobiology spectrum2026

Exploring the activity of a novel orally bioavailable β-lactam-β-lactamase inhibitor combination, ceftibuten-ledaborbactam, against Enterobacterales-carrying

Maria F Mojica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.